Literature DB >> 9671330

Factors influencing quality of life in cancer patients: anemia and fatigue.

D Cella1.   

Abstract

Anemia is a multi-symptom syndrome involving both physical and emotional problems that can be evaluated for their impact on quality of life. Fatigue is the cardinal symptom of anemia, reported by three of four cancer patients using the general version of the Functional Assessment of Cancer Therapy (FACT-G) questionnaire. A subscale of the FACT-G, consisting of the FACT-Fatigue (FACT-F) and the FACT-Anemia (FACT-An), has been developed to specifically address this problem. The FACT-F is comprised of the FACT-G plus 13 questions related to fatigue, while the FACT-An is comprised of the FACT-F plus an additional set of seven miscellaneous (non-fatigue) questions relevant to anemia in cancer patients. The FACT-An subscale was initially validated in a cohort of 50 cancer patients. Tests of internal consistency and stability confirmed the reliability of the fatigue component, as well as that of the FACT-G (27 items), the FACT-F (FACT-G plus 13 fatigue items), and the FACT-An (FACT-G plus 20 anemia subscale items) measurement systems. Quality of life scores on these FACT scales significantly decline as patient performance status worsens, and the scales correlate well with other questionnaires (Profile of Mood States and Piper Fatigue Scale) purported to measure the same thing. The scores on the FACT-An subscale also clearly differentiate between patients with low and high hemoglobin levels. Low hemoglobin levels are associated with greater fatigue, poorer overall quality of life, and decreased ability to work (beyond that related directly to fatigue). Interventions that reverse fatigue and other anemia-related symptoms should have a positive effect on quality of life.

Entities:  

Mesh:

Year:  1998        PMID: 9671330

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  79 in total

1.  Further validation of the multidimensional fatigue symptom inventory-short form.

Authors:  Kevin D Stein; Paul B Jacobsen; Chris M Blanchard; Christina Thors
Journal:  J Pain Symptom Manage       Date:  2004-01       Impact factor: 3.612

2.  Epoetin alfa increases hemoglobin levels and improves quality of life in anemic geriatric cancer patients receiving chemotherapy.

Authors:  Matti S Aapro; David C Dale; Michael Blasi; Brenda Sarokhan; Fawzia Ahmed; Richard C Woodman
Journal:  Support Care Cancer       Date:  2006-06-07       Impact factor: 3.603

3.  Intraclass correlation metrics for the accuracy of algorithmic definitions in a computerized decision support system for supportive cancer care.

Authors:  Matti Aapro; Ivo Abraham; Karen MacDonald; Pierre Soubeyran; Jan Foubert; Carsten Bokemeyer; Michael Muenzberg; Joanna Van Erps; Matthew Turner
Journal:  Support Care Cancer       Date:  2007-03-29       Impact factor: 3.603

4.  Classical test theory and item response theory/Rasch model to assess differences between patient-reported fatigue using 7-day and 4-week recall periods.

Authors:  Jin-Shei Lai; Karon Cook; Arthur Stone; Jennifer Beaumont; David Cella
Journal:  J Clin Epidemiol       Date:  2009-02-12       Impact factor: 6.437

5.  Effects of nutritional and psychological status of the patients with advanced stomach cancer on physical performance status.

Authors:  Jun Tian; Zhen-chun Chen; Li-Fang Hang
Journal:  Support Care Cancer       Date:  2009-01-27       Impact factor: 3.603

6.  Cost-utility analysis of survival with epoetin-alfa versus placebo in stage IV breast cancer.

Authors:  Silas C Martin; Dennis D Gagnon; Lucy Zhang; Carsten Bokemeyer; Marinus Van Marwijk Kooy; Ben van Hout
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

7.  The background and methodology of the Anaemia Cancer Treatment (A.C.T.) study: a global retrospective study of practice patterns and outcomes in the management of anaemia in cancer patients and their congruence with evidence-based guidelines.

Authors:  Matti Aapro; Ivo Abraham; Carsten Bokemeyer; Heinz Ludwig; Karen Macdonald; Pierre Soubeyran; Matthew Turner
Journal:  Support Care Cancer       Date:  2007-09-14       Impact factor: 3.603

8.  Promoting evidence-based management of anemia in cancer patients: concurrent and discriminant validity of RESPOND, a web-based clinical guidance system based on the EORTC guidelines for supportive care in cancer.

Authors:  Joanna Van Erps; Matti Aapro; Karen MacDonald; Pierre Soubeyran; Matthew Turner; Hans Warrinnier; Tara Albrecht; Ivo Abraham
Journal:  Support Care Cancer       Date:  2009-11-11       Impact factor: 3.603

9.  Pharmacokinetic and pharmacodynamic profiles of subcutaneous administration of continuous erythropoietin receptor activator in lung cancer patients with anemia induced by chemotherapy.

Authors:  Toshiaki Takahashi; Nobuyuki Yamamoto; Tomohide Tamura; Hideo Kunitoh; Yutaka Nishiwaki; Shunichi Negoro
Journal:  Oncol Lett       Date:  2011-08-29       Impact factor: 2.967

10.  Prevalence and management of anaemia in haematologic cancer patients receiving cyclic nonplatinum chemotherapy: results of a prospective national chart survey.

Authors:  Michael Steurer; Helga Wagner; Günther Gastl
Journal:  Wien Klin Wochenschr       Date:  2004-06-30       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.